Analysis of the methods for projection of spaces for good manufacturing practice
Main Article Content
Abstract
BACKGROUND: In this Paper we will present the evolution of the best practice for biobanks, the technical and medical standards for collecting, processing and storing, as well as the socio-economic standards for biobank management.
AIM: The aim of this Thesis is to analyse and to present the methods for projection of spaces for good manufacturing practice.
METHODS: The European Union has adopted guidelines for good manufacturing practice which define the requirements for manufacturing of sterile products. In the following text we will describe the details for determining microbiological cleanliness and cleanliness of the particles in the air, on the surfaces, etc.
RESULTS: The length of time between the collecting of blood or tissues could affect the final result. The preparation of sterile products requires special conditions, in order the risk of microbiological contamination and certain pyrogenic contaminations to be minimized. We make difference between four levels of guidelines for good manufacturing practice, which in this Paper are taken from the practice of the European Union. Level A is local zone with high-risk procedures, e.g. filling, closing of bottles, opening of ampoules and bottles and making septic connections. Level B is aseptic preparation and filling of the samples. Level C and D are the clean spaces for less critical procedures for preparation of sterile products.
CONCLUSION: Technical standards, medical standards, socio-economic standards for biobank management, informatics practices for biobanks, economic recommendations for biobanks have been established, as well as a quality of biobanks has been provided.
Downloads
Plum Analytics Artifact
Article Details
http://creativecommons.org/licenses/by-nc/4.0
References
Eiseman E, Haga SB, editors. Handbook of human tissue sources: a national resource of human tissue samples. Santa Monica, CA: RAND Corporation; 1999.
Riegman PH, Dinjens WN, Oosterhuis JW. Biobanking for interdisciplinary clinical research. Pathobiology. 2007; 74:239-44.
https://doi.org/10.1159/000104451 DOI: https://doi.org/10.1159/000104451
Hughes S, Barnes RO, Watson PH. Biospecimen use in cancer research over two decades. Biopreserv Biobanking. 2010; 8:89-97. https://doi.org/10.1089/bio.2010.0005 DOI: https://doi.org/10.1089/bio.2010.0005
Vaught J, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010; 19:912-5. https://doi.org/10.1158/1055-9965.EPI-10-0058
Moore HM, Compton CC, Alper J, Vaught JB. International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev. 2011; 20:729-32. https://doi.org/10.1158/1055-9965.EPI-11-0021 DOI: https://doi.org/10.1158/1055-9965.EPI-11-0021
Hatzis C, Sun H, Yao H, Hubbard RE, Meric-Bernstam F, Babiera YW, et al. Perioperative ischemia and tissue preservation effects on RNA integ239rity and microarrays of breast cancer. J Natl Cancer Inst. 2011; 103:1871-83. https://doi.org/10.1093/jnci/djr438 DOI: https://doi.org/10.1093/jnci/djr438
Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ. Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum. Clin Chem. 2001; 47:139-42. https://doi.org/10.1093/clinchem/47.1.139 DOI: https://doi.org/10.1093/clinchem/47.1.139
Vaught JB. Blood collection, shipment, processing and storage. Cancer Epidemiol Biomarkers Prev. 2006; 15:1582-4. https://doi.org/10.1158/1055-9965.EPI-06-0630 DOI: https://doi.org/10.1158/1055-9965.EPI-06-0630
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Khoury T, Sai S, Hwang J, et al. Delay to formalin fixation effect on breast biomarkers. Mod Pathol. 2009; 22:1457-67. https://doi.org/10.1038/modpathol.2009.117 DOI: https://doi.org/10.1038/modpathol.2009.117
ISBER best practices for repositories. Cell Preserv Technol. 2008; 6:1-58. https://doi.org/10.1089/cpt.2008.9996 DOI: https://doi.org/10.1089/cpt.2008.9996
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Vaught J, Caboux E, Hainaut P. International efforts to develop biospecimen best practices. Cancer Epidemiol Biomarkers Prev. 2010; 19:912-5. https://doi.org/10.1158/1055-9965.EPI-10-0058 DOI: https://doi.org/10.1158/1055-9965.EPI-10-0058
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
NCI Best Practices for biospecimen resources. Table of contents. http://biospecimens. cancer.gov/bestpractices/toc/2011 Accessed March 6, 2012.
Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a national cancer human biobank by the National Cancer Institute. JNCI Monogr. 2011; 42:24-31. https://doi.org/10.1093/jncimonographs/lgr009
Vaught J, Rogers J, Carolin T, Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a national cancer human biobank by the National Cancer Institute. JNCI Monogr. 2011; 42:24-31. https://doi.org/10.1093/jncimonographs/lgr009 DOI: https://doi.org/10.1093/jncimonographs/lgr009
Centers for Disease Control and Prevention laboratory quality assurance and standardization program. http://www.cdc.gov/labstandards/ Accessed March 9, 2012.
Master Control web site. http://www.mastercontrol.com/document-control-software/ Accessed March 9, 2012.
Centers for Disease Control and Prevention laboratory quality assurance and standardization program. http://www.cdc.gov/labstandards/ Accessed March 9, 2012.
EudraLex. The Rules Governing Medicinal Products in the European Union. Volume 4. EU Guidelines to Good Manufacturing Medicinal Products for Human and Veterinary Use. EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL: Brussels, 25 November 2008.
EudraLex. The Rules Governing Medicinal Products in the European Union. Volume 4. EU Guidelines to Good Manufacturing Medicinal Products for Human and Veterinary Use. EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL: Brussels, 25 November 2008.
UNI-EN-ISO 14644-1/2/3/4/5/7 regulations.